These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


788 related items for PubMed ID: 17451401

  • 1. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
    Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB.
    Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
    Lapham S, Forman R, Alexander M, Illeperuma A, Bohn MJ.
    J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
    [Abstract] [Full Text] [Related]

  • 14. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ.
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH, Gueorguieva R, Cramer J, Collins J, Rosenheck R, VA CSP No. 425 Study Team.
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
    Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK.
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638
    [Abstract] [Full Text] [Related]

  • 19. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker.
    Ait-Daoud N, Johnson BA, Javors M, Roache JD, Zanca NA.
    Alcohol Clin Exp Res; 2001 Jun; 25(6):847-9. PubMed ID: 11410720
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.